EPCR gene A3 haplotype and elevated soluble endothelial protein C receptor (sEPCR) levels in Turkish pediatric stroke patients

Arzu Ulu, Denizay Gunal, Serap Tiras, Yonca Egin, Gülhis Deda, Nejat Akar

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Introduction: High plasma levels of sEPCR lead to dysfunction of the EPCR-mediated coagulation. We have evaluated the role of EPCR A3 haplotype with its representative promoter variant 1651 C-G in a total of twenty-seven pediatric stroke patients and fifty-nine healthy subjects. Materials and methods: Genotyping of the A3 haplotype was performed with RFLP analysis. Plasma sEPCR levels were measured with ELISA. The mutant 1651 G allele frequency was observed to be 0.166 in the patient group. Common risk factors such as FV 1691 G-A and PT 20210 G-A mutations were also screened. Results and conclusions: None of the patients with sEPCR levels below 100 ng/ml carried the A3 haplotype, while patients with elevated sEPCR levels carried the A3 haplotype either in a heterozygous or homozygous state. Our study confirms that there is a strong association between A3 haplotype and elevated sEPCR levels. We suggest that elevated sEPCR levels might increase the risk of stroke at pediatric age when compared to controls. Studies with large series of patients are warranted to confirm this hypothesis.

Original languageEnglish (US)
Pages (from-to)47-52
Number of pages6
JournalThrombosis Research
Volume120
Issue number1
DOIs
StatePublished - 2007
Externally publishedYes

Fingerprint

Protein C
Haplotypes
Stroke
Pediatrics
Genes
Gene Frequency
Restriction Fragment Length Polymorphisms
Healthy Volunteers
Enzyme-Linked Immunosorbent Assay
Mutation

Keywords

  • A3 haplotype
  • EPCR gene
  • Pediatric stroke
  • sEPCR levels

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Hematology

Cite this

EPCR gene A3 haplotype and elevated soluble endothelial protein C receptor (sEPCR) levels in Turkish pediatric stroke patients. / Ulu, Arzu; Gunal, Denizay; Tiras, Serap; Egin, Yonca; Deda, Gülhis; Akar, Nejat.

In: Thrombosis Research, Vol. 120, No. 1, 2007, p. 47-52.

Research output: Contribution to journalArticle

Ulu, Arzu ; Gunal, Denizay ; Tiras, Serap ; Egin, Yonca ; Deda, Gülhis ; Akar, Nejat. / EPCR gene A3 haplotype and elevated soluble endothelial protein C receptor (sEPCR) levels in Turkish pediatric stroke patients. In: Thrombosis Research. 2007 ; Vol. 120, No. 1. pp. 47-52.
@article{97390dc4b97d482fa64d2478d24f2a8c,
title = "EPCR gene A3 haplotype and elevated soluble endothelial protein C receptor (sEPCR) levels in Turkish pediatric stroke patients",
abstract = "Introduction: High plasma levels of sEPCR lead to dysfunction of the EPCR-mediated coagulation. We have evaluated the role of EPCR A3 haplotype with its representative promoter variant 1651 C-G in a total of twenty-seven pediatric stroke patients and fifty-nine healthy subjects. Materials and methods: Genotyping of the A3 haplotype was performed with RFLP analysis. Plasma sEPCR levels were measured with ELISA. The mutant 1651 G allele frequency was observed to be 0.166 in the patient group. Common risk factors such as FV 1691 G-A and PT 20210 G-A mutations were also screened. Results and conclusions: None of the patients with sEPCR levels below 100 ng/ml carried the A3 haplotype, while patients with elevated sEPCR levels carried the A3 haplotype either in a heterozygous or homozygous state. Our study confirms that there is a strong association between A3 haplotype and elevated sEPCR levels. We suggest that elevated sEPCR levels might increase the risk of stroke at pediatric age when compared to controls. Studies with large series of patients are warranted to confirm this hypothesis.",
keywords = "A3 haplotype, EPCR gene, Pediatric stroke, sEPCR levels",
author = "Arzu Ulu and Denizay Gunal and Serap Tiras and Yonca Egin and G{\"u}lhis Deda and Nejat Akar",
year = "2007",
doi = "10.1016/j.thromres.2006.08.004",
language = "English (US)",
volume = "120",
pages = "47--52",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - EPCR gene A3 haplotype and elevated soluble endothelial protein C receptor (sEPCR) levels in Turkish pediatric stroke patients

AU - Ulu, Arzu

AU - Gunal, Denizay

AU - Tiras, Serap

AU - Egin, Yonca

AU - Deda, Gülhis

AU - Akar, Nejat

PY - 2007

Y1 - 2007

N2 - Introduction: High plasma levels of sEPCR lead to dysfunction of the EPCR-mediated coagulation. We have evaluated the role of EPCR A3 haplotype with its representative promoter variant 1651 C-G in a total of twenty-seven pediatric stroke patients and fifty-nine healthy subjects. Materials and methods: Genotyping of the A3 haplotype was performed with RFLP analysis. Plasma sEPCR levels were measured with ELISA. The mutant 1651 G allele frequency was observed to be 0.166 in the patient group. Common risk factors such as FV 1691 G-A and PT 20210 G-A mutations were also screened. Results and conclusions: None of the patients with sEPCR levels below 100 ng/ml carried the A3 haplotype, while patients with elevated sEPCR levels carried the A3 haplotype either in a heterozygous or homozygous state. Our study confirms that there is a strong association between A3 haplotype and elevated sEPCR levels. We suggest that elevated sEPCR levels might increase the risk of stroke at pediatric age when compared to controls. Studies with large series of patients are warranted to confirm this hypothesis.

AB - Introduction: High plasma levels of sEPCR lead to dysfunction of the EPCR-mediated coagulation. We have evaluated the role of EPCR A3 haplotype with its representative promoter variant 1651 C-G in a total of twenty-seven pediatric stroke patients and fifty-nine healthy subjects. Materials and methods: Genotyping of the A3 haplotype was performed with RFLP analysis. Plasma sEPCR levels were measured with ELISA. The mutant 1651 G allele frequency was observed to be 0.166 in the patient group. Common risk factors such as FV 1691 G-A and PT 20210 G-A mutations were also screened. Results and conclusions: None of the patients with sEPCR levels below 100 ng/ml carried the A3 haplotype, while patients with elevated sEPCR levels carried the A3 haplotype either in a heterozygous or homozygous state. Our study confirms that there is a strong association between A3 haplotype and elevated sEPCR levels. We suggest that elevated sEPCR levels might increase the risk of stroke at pediatric age when compared to controls. Studies with large series of patients are warranted to confirm this hypothesis.

KW - A3 haplotype

KW - EPCR gene

KW - Pediatric stroke

KW - sEPCR levels

UR - http://www.scopus.com/inward/record.url?scp=34247108701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247108701&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2006.08.004

DO - 10.1016/j.thromres.2006.08.004

M3 - Article

C2 - 17027065

AN - SCOPUS:34247108701

VL - 120

SP - 47

EP - 52

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - 1

ER -